Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02968446 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Vitamin D After Application With Valchlor
A Early Phase 1 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 33
- Enrollment target
NCT02968446 is a Early Phase 1 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 33 participants.
The verdict
NCT02968446, a Early Phase 1 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the effects of an oral Vitamin D on the body's immune system. An interest has been growing because studies have shown that Vitamin D may reduce inflammation and harmful effects in the body, however, the best dose for Vitamin D is still unknown. Inflammation is the body's physical response to infection, injury, or long term disease. Pain, redness, heat, and sometimes loss of function are all signs of inflammation in the body. This study will look at product use, testing skin irritation in healthy volunteers and seeing how Vitamin D may help stop or reduce inflammation and skin irritation, which could one day help doctors prescribe Vitamin D to patients with long term disease to relieve their symptoms.
Interventions
- DRUG Valchlor
- DIETARY_SUPPLEMENT 4 placebo
- DIETARY_SUPPLEMENT 4 Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2016-11-17 |
| Est. Completion | 2018-10-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02968446
The ClinicalTrials.gov registry entry for NCT02968446 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Valchlor is the first listed.
NCT02968446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02968446 about?
NCT02968446 is a clinical study titled "Effect of Vitamin D After Application With Valchlor". The purpose of this research study is to evaluate the effects of an oral Vitamin D on the body's immune system. An interest has been growing because studies have shown that Vitamin D may reduce inflammation and harmful effects in the body, however, the best dose for Vitamin D is still unknown. Inf...
What is the current status of trial NCT02968446?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 33 participants. The study started on 2016-11-17. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT02968446?
The interventions under investigation include: Valchlor (DRUG), 4 placebo (DIETARY_SUPPLEMENT), 4 Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02968446?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.